The Impact of Covid-19 Pandemic on the Pharmaceutical Industry

Yiting Hu (), Ziting Huo, Ximiao Zhai and Ziheng Zu
Additional contact information
Yiting Hu: Shanghai Normal University
Ziting Huo: Dalian American International School
Ximiao Zhai: Windermere Preparatory High School
Ziheng Zu: The High School Affiliated to Beijing Normal University

A chapter in Proceedings of the 2022 2nd International Conference on Financial Management and Economic Transition (FMET 2022), 2023, pp 415-426 from Springer

Abstract: Abstract On March 11, 2020, the World Health Organization declared the 2019 novel coronavirus disease (COVID-19) a global pandemic. This pandemic is bound to have a significant impact on the health market, and pharmaceutical industry, which may bring huge business opportunities or threats to pharmaceutical manufacturing companies; This study use SWOT analysis to provide implication for individuals or organizations identify business competition or project planning related issues Strengths, Weaknesses, Opportunities, and Threats in order to investigate the impact of pandemic bring to the China pharmaceutical industry.

Keywords: pharmaceutical; industry; SWOT analysis; FOSUN; COVID-19 pandemic; economic impact (search for similar items in EconPapers)
Date: 2023
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:advbcp:978-94-6463-054-1_45

Ordering information: This item can be ordered from
http://www.springer.com/9789464630541

DOI: 10.2991/978-94-6463-054-1_45

Access Statistics for this chapter

More chapters in Advances in Economics, Business and Management Research from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().